Natco Pharma shares surge 5.3 pc after patent ruling Shares in Natco Pharma Ltd surge 5.3 per cent after an Indian patent appeals board upheld on Monday a decision to allow the company to sell a generic version of Bayer AG's cancer drug Nexavar. ...  
12:35 PM, Mar 05, 2013